206 related articles for article (PubMed ID: 34452467)
1. IFN-λ1 Displays Various Levels of Antiviral Activity In Vitro in a Select Panel of RNA Viruses.
Plotnikova M; Lozhkov A; Romanovskaya-Romanko E; Baranovskaya I; Sergeeva M; Kаа K; Klotchenko S; Vasin A
Viruses; 2021 Aug; 13(8):. PubMed ID: 34452467
[TBL] [Abstract][Full Text] [Related]
2. Antiviral Activity of Type I, II, and III Interferons Counterbalances ACE2 Inducibility and Restricts SARS-CoV-2.
Busnadiego I; Fernbach S; Pohl MO; Karakus U; Huber M; Trkola A; Stertz S; Hale BG
mBio; 2020 Sep; 11(5):. PubMed ID: 32913009
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of the Anti-Viral Activity of Human Recombinant Interferon Lambda-1 against SARS-CoV-2.
Madonov PG; Svyatchenko VA; Legostaev SS; Kikhtenko NA; Kotlyarova AA; Oleinik LA; Baikalov GI
Bull Exp Biol Med; 2021 Nov; 172(1):53-56. PubMed ID: 34791556
[TBL] [Abstract][Full Text] [Related]
4. Alpha/beta interferon (IFN-alpha/beta)-independent induction of IFN-lambda1 (interleukin-29) in response to Hantaan virus infection.
Stoltz M; Klingström J
J Virol; 2010 Sep; 84(18):9140-8. PubMed ID: 20592090
[TBL] [Abstract][Full Text] [Related]
5. Lambda interferon (IFN-lambda), a type III IFN, is induced by viruses and IFNs and displays potent antiviral activity against select virus infections in vivo.
Ank N; West H; Bartholdy C; Eriksson K; Thomsen AR; Paludan SR
J Virol; 2006 May; 80(9):4501-9. PubMed ID: 16611910
[TBL] [Abstract][Full Text] [Related]
6. Design and evaluation of novel interferon lambda analogs with enhanced antiviral activity and improved drug attributes.
Yu D; Zhao M; Dong L; Zhao L; Zou M; Sun H; Zhang M; Liu H; Zou Z
Drug Des Devel Ther; 2016; 10():163-82. PubMed ID: 26792983
[TBL] [Abstract][Full Text] [Related]
7. Type III interferon (IFN-lambda) antagonizes the antiviral activity of interferon-alpha in vitro.
Bordi L; Lalle E; Lapa D; Caglioti C; Quartu S; Capobianchi MR; Castilletti C
J Biol Regul Homeost Agents; 2013; 27(4):1001-9. PubMed ID: 24382181
[TBL] [Abstract][Full Text] [Related]
8. Differential interferon-α subtype induced immune signatures are associated with suppression of SARS-CoV-2 infection.
Schuhenn J; Meister TL; Todt D; Bracht T; Schork K; Billaud JN; Elsner C; Heinen N; Karakoese Z; Haid S; Kumar S; Brunotte L; Eisenacher M; Di Y; Lew J; Falzarano D; Chen J; Yuan Z; Pietschmann T; Wiegmann B; Uebner H; Taube C; Le-Trilling VTK; Trilling M; Krawczyk A; Ludwig S; Sitek B; Steinmann E; Dittmer U; Lavender KJ; Sutter K; Pfaender S
Proc Natl Acad Sci U S A; 2022 Feb; 119(8):. PubMed ID: 35131898
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of SARS-CoV-2 by type I and type III interferons.
Felgenhauer U; Schoen A; Gad HH; Hartmann R; Schaubmar AR; Failing K; Drosten C; Weber F
J Biol Chem; 2020 Oct; 295(41):13958-13964. PubMed ID: 32587093
[TBL] [Abstract][Full Text] [Related]
10. Antiviral activity of type I and type III interferons against porcine reproductive and respiratory syndrome virus (PRRSV).
Luo R; Fang L; Jin H; Jiang Y; Wang D; Chen H; Xiao S
Antiviral Res; 2011 Aug; 91(2):99-101. PubMed ID: 21569798
[TBL] [Abstract][Full Text] [Related]
11. Generation and characterization of interferon-lambda 1-resistant H1N1 influenza A viruses.
Ilyushina NA; Lugovtsev VY; Samsonova AP; Sheikh FG; Bovin NV; Donnelly RP
PLoS One; 2017; 12(7):e0181999. PubMed ID: 28750037
[TBL] [Abstract][Full Text] [Related]
12. IFN-λ Inhibits MiR-122 Transcription through a Stat3-HNF4α Inflammatory Feedback Loop in an IFN-α Resistant HCV Cell Culture System.
Aboulnasr F; Hazari S; Nayak S; Chandra PK; Panigrahi R; Ferraris P; Chava S; Kurt R; Song K; Dash A; Balart LA; Garry RF; Wu T; Dash S
PLoS One; 2015; 10(12):e0141655. PubMed ID: 26657215
[TBL] [Abstract][Full Text] [Related]
13. Increased Sensitivity of SARS-CoV-2 to Type III Interferon in Human Intestinal Epithelial Cells.
Metz-Zumaran C; Kee C; Doldan P; Guo C; Stanifer ML; Boulant S
J Virol; 2022 Apr; 96(7):e0170521. PubMed ID: 35262371
[TBL] [Abstract][Full Text] [Related]
14. Interferon lambda induces antiviral response to herpes simplex virus 1 infection.
Lopušná K; Režuchová I; Kabát P; Kúdelová M
Acta Virol; 2014; 58(4):325-32. PubMed ID: 25518713
[TBL] [Abstract][Full Text] [Related]
15. Antiviral activity of lambda interferon in chickens.
Reuter A; Soubies S; Härtle S; Schusser B; Kaspers B; Staeheli P; Rubbenstroth D
J Virol; 2014 Mar; 88(5):2835-43. PubMed ID: 24371053
[TBL] [Abstract][Full Text] [Related]
16. Antagonistic antiviral activity between IFN-lambda and IFN-alpha against lethal Crimean-Congo hemorrhagic fever virus in vitro.
Bordi L; Lalle E; Caglioti C; Travaglini D; Lapa D; Marsella P; Quartu S; Kis Z; Arien KK; Huemer HP; Meschi S; Ippolito G; Di Caro A; Capobianchi MR; Castilletti C
PLoS One; 2015; 10(2):e0116816. PubMed ID: 25693189
[TBL] [Abstract][Full Text] [Related]
17. Loss of the Nuclear Protein RTF2 Enhances Influenza Virus Replication.
Chia BS; Li B; Cui A; Eisenhaure T; Raychowdhury R; Lieb D; Hacohen N
J Virol; 2020 Oct; 94(22):. PubMed ID: 32878895
[TBL] [Abstract][Full Text] [Related]
18. Different Mechanisms Are Utilized by Coronavirus Transmissible Gastroenteritis Virus To Regulate Interferon Lambda 1 and Interferon Lambda 3 Production.
Xue M; Wang W; He H; Li L; Zhang X; Shi H; Liu P; Feng L
J Virol; 2022 Dec; 96(24):e0138822. PubMed ID: 36448799
[TBL] [Abstract][Full Text] [Related]
19. Type I and Type III Interferons Restrict SARS-CoV-2 Infection of Human Airway Epithelial Cultures.
Vanderheiden A; Ralfs P; Chirkova T; Upadhyay AA; Zimmerman MG; Bedoya S; Aoued H; Tharp GM; Pellegrini KL; Manfredi C; Sorscher E; Mainou B; Lobby JL; Kohlmeier JE; Lowen AC; Shi PY; Menachery VD; Anderson LJ; Grakoui A; Bosinger SE; Suthar MS
J Virol; 2020 Sep; 94(19):. PubMed ID: 32699094
[TBL] [Abstract][Full Text] [Related]
20. Combinations of lambda interferon with direct-acting antiviral agents are highly efficient in suppressing hepatitis C virus replication.
Friborg J; Levine S; Chen C; Sheaffer AK; Chaniewski S; Voss S; Lemm JA; McPhee F
Antimicrob Agents Chemother; 2013 Mar; 57(3):1312-22. PubMed ID: 23274666
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
